157 related articles for article (PubMed ID: 37867929)
1. Utilizing two-dimensional monolayer and three-dimensional spheroids to enhance radiotherapeutic potential by combining gold nanoparticles and docetaxel.
Bromma K; Beckham W; Chithrani DB
Cancer Nanotechnol; 2023; 14(1):80. PubMed ID: 37867929
[TBL] [Abstract][Full Text] [Related]
2. Three-Dimensional Tumor Spheroids as a Tool for Reliable Investigation of Combined Gold Nanoparticle and Docetaxel Treatment.
Bromma K; Alhussan A; Perez MM; Howard P; Beckham W; Chithrani DB
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33806801
[TBL] [Abstract][Full Text] [Related]
3. Dual enhancement in the radiosensitivity of prostate cancer through nanoparticles and chemotherapeutics.
Jackson N; Hill I; Alhussan A; Bromma K; Morgan J; Abousaida B; Zahra Y; Mackeyev Y; Beckham W; Herchko S; Krishnan S; Chithrani DB
Cancer Nanotechnol; 2023; 14(1):75. PubMed ID: 37781236
[TBL] [Abstract][Full Text] [Related]
4. Enhancing nanoparticle accumulation in two dimensional, three dimensional, and xenograft mouse cancer cell models in the presence of docetaxel.
Bromma K; Dos Santos N; Barta I; Alexander A; Beckham W; Krishnan S; Chithrani DB
Sci Rep; 2022 Aug; 12(1):13508. PubMed ID: 35931743
[TBL] [Abstract][Full Text] [Related]
5. Modulation of nanoparticle uptake, intracellular distribution, and retention with docetaxel to enhance radiotherapy.
Bannister AH; Bromma K; Sung W; Monica M; Cicon L; Howard P; Chow RL; Schuemann J; Chithrani DB
Br J Radiol; 2020 Feb; 93(1106):20190742. PubMed ID: 31778316
[TBL] [Abstract][Full Text] [Related]
6. Lipid-Nanoparticle-Mediated Delivery of Docetaxel Prodrug for Exploiting Full Potential of Gold Nanoparticles in the Treatment of Pancreatic Cancer.
Alhussan A; Jackson N; Eaton S; Santos ND; Barta I; Zaifman J; Chen S; Tam YYC; Krishnan S; Chithrani DB
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551622
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of Low Concentrations of Gold Nanoparticles: Complex Effects on Radiation Response and Fate of Cancer Cells.
Dobešová L; Gier T; Kopečná O; Pagáčová E; Vičar T; Bestvater F; Toufar J; Bačíková A; Kopel P; Fedr R; Hildenbrand G; Falková I; Falk M; Hausmann M
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057061
[No Abstract] [Full Text] [Related]
8. Utilizing Gold Nanoparticles as Prospective Radiosensitizers in 3D Radioresistant Pancreatic Co-Culture Model.
Alhussan A; Jackson N; Calisin R; Morgan J; Beckham W; Chithrani DB
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569898
[TBL] [Abstract][Full Text] [Related]
9. Modeling gold nanoparticle radiosensitization using a clustering algorithm to quantitate DNA double-strand breaks with mixed-physics Monte Carlo simulation.
Liu R; Zhao T; Zhao X; Reynoso FJ
Med Phys; 2019 Nov; 46(11):5314-5325. PubMed ID: 31505039
[TBL] [Abstract][Full Text] [Related]
10. Investigating the Sonodynamic-Radiosensitivity Effect of Gold Nanoparticles on HeLa Cervical Cancer Cells.
Shanei A; Akbari-Zadeh H
J Korean Med Sci; 2019 Sep; 34(37):e243. PubMed ID: 31559711
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development.
Ekert JE; Johnson K; Strake B; Pardinas J; Jarantow S; Perkinson R; Colter DC
PLoS One; 2014; 9(3):e92248. PubMed ID: 24638075
[TBL] [Abstract][Full Text] [Related]
12. Multicellular tumor spheroids for evaluation of cytotoxicity and tumor growth inhibitory effects of nanomedicines in vitro: a comparison of docetaxel-loaded block copolymer micelles and Taxotere®.
Mikhail AS; Eetezadi S; Allen C
PLoS One; 2013; 8(4):e62630. PubMed ID: 23626842
[TBL] [Abstract][Full Text] [Related]
13. Gold nanoparticle induced vasculature damage in radiotherapy: Comparing protons, megavoltage photons, and kilovoltage photons.
Lin Y; Paganetti H; McMahon SJ; Schuemann J
Med Phys; 2015 Oct; 42(10):5890-902. PubMed ID: 26429263
[TBL] [Abstract][Full Text] [Related]
14. Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes.
Grayson KA; Jyotsana N; Ortiz-Otero N; King MR
PLoS One; 2021; 16(3):e0246733. PubMed ID: 33661931
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment with 17-N-allylamino-17-demethoxy geldanamycin and acute irradiation produces supra-additive growth suppression in human prostate carcinoma spheroids.
Enmon R; Yang WH; Ballangrud AM; Solit DB; Heller G; Rosen N; Scher HI; Sgouros G
Cancer Res; 2003 Dec; 63(23):8393-9. PubMed ID: 14679001
[TBL] [Abstract][Full Text] [Related]
16. Keratin nanoparticles co-delivering Docetaxel and Chlorin e6 promote synergic interaction between chemo- and photo-dynamic therapies.
Gaio E; Guerrini A; Ballestri M; Varchi G; Ferroni C; Martella E; Columbaro M; Moret F; Reddi E
J Photochem Photobiol B; 2019 Oct; 199():111598. PubMed ID: 31465971
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitization effect of radiofrequency hyperthermia in the presence of PEGylated-gold nanoparticles on the MCF-7 breast cancer cells under 6 MeV electron irradiation.
Mohammadi A; Hashemi B; Mehdi Mahdavi SR; Solimani M; Banaei A
J Cancer Res Ther; 2023 Apr; 19(Supplement):S67-S73. PubMed ID: 37147985
[TBL] [Abstract][Full Text] [Related]
18. Response of breast cancer carcinoma spheroids to combination therapy with radiation and DNA-PK inhibitor: growth arrest without a change in
Yu J; Lu R; Nedrow JR; Sgouros G
Int J Radiat Biol; 2020 Dec; 96(12):1534-1540. PubMed ID: 33074046
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
[TBL] [Abstract][Full Text] [Related]
20. From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer.
Rodallec A; Sicard G; Giacometti S; Carré M; Pourroy B; Bouquet F; Savina A; Lacarelle B; Ciccolini J; Fanciullino R
Int J Nanomedicine; 2018; 13():6677-6688. PubMed ID: 30425482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
